VXRT (Vaxart Inc.) Prakiraan rega marang bathi

Simbol resmi perusahaan Vaxart Inc. (VXRT)

Vaxart, Inc. (VXRT) is implementing revolutionary tablet vaccines, simplifying logistics and eliminating injections. The company's forward P/E ratio demonstrates the business valuation's adaptation to regulator rates, with the parameter reaching 0.00. The development of a unique influenza platform creates a significant defensive moat. Stable plant operations and reactor upgrades ensure the uninterrupted production of drugs within clean zones.

VXRT - Kapitalisasi marang proyeksi bathi vaxart.com ing rentang 04.07.2022 - 19.07.2025

Rincian analitis perusahaan Vaxart, Inc.

- rega saiki lan proyeksi nilai saham:
Kutipan saham Vaxart Inc.|VXRT - Konsensus nilai wajar
- indikator valuasi pasar bisnis:
Biji pasar Vaxart, Inc.|VXRT - Nilai Total Perusahaan
- statistik nilai buku emiten:
Nilai Buku saben Saham Vaxart|VXRT - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku vaxart.com|VXRT - Nilai Agregat Aset
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Vaxart, Inc.|VXRT - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Vaxart Corp|VXRT - Gunggung kewajiban utang perusahaan|Utang marang nilai buku Vaxart, Inc.|VXRT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Vaxart|Indikator likuiditas cepet vaxart.com
- statistik bathi lan rasio pasar:
VXRT - Bathi perusahaan|Proyeksi bathi mangsa ngarep Vaxart, Inc.|VXRT - Pangali P/E|Rega marang bathi mangsa ngarep Vaxart Inc.|VXRT - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Vaxart Inc.|VXRT - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Vaxart|VXRT - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan vaxart.com|VXRT - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Vaxart, Inc.
- data pendapatan lan penerimaan dodolan:
VXRT - Volume dodolan perusahaan|Prakiraan volume dodolan Vaxart Inc.|VXRT - Kapitalisasi marang pendapatan|Multiplikator forward rega marang pendapatan Vaxart, Inc.|VXRT - Wutah pendapatan taunan sajrone rolas wulan kepungkur
Analisis dhasar perusahaan:Vaxart Corp VXRT
Sampel barang Vaxart, Inc.

For the flexible biotech model of Vaxart, Inc. (VXRT), which minimizes capital expenditures through production outsourcing, the company's forward P/E NTM serves as an indicator of market expectations regarding future profitability. The ratio of the current share price to projected net income under the Federal Reserve's tight monetary policy allows for an assessment of business resilience and helps determine a fair entry threshold for the asset.

Perusahaan pesaing

Prakiraan rega marang bathi GILD (Gilead Sciences Inc)|CDTX (Cidara Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Novavax, Inc. - Prakiraan rega marang bathi|CureVac N.V. - Rega marang bathi mangsa ngarep|Valneva Corp - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi VIR (Vir Bio)|SIGA Corp (SIGA) - Rega marang bathi mangsa ngarep|Emergent Bio (EBS) - Pangali Forward P/E|Prakiraan rega marang bathi AVIR|Pangali Forward P/E invivyd.com|Rega marang bathi mangsa ngarep Enanta Pharmaceuticals Inc. (ENTA)|Kapitalisasi marang proyeksi bathi Inovio Pharmaceuticals, Inc.|Pangali Forward P/E HLVX (HilleVax Corp)|Pangali Forward P/E Kalaris Therapeutics, Inc. KLRS|DYAI: Prakiraan rega marang bathi|NNVC - Pangali Forward P/E|Talphera (TLPH) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Cocrystal Pharma Inc|Prakiraan rega marang bathi TRAW|Prakiraan rega marang bathi dwtx.com (DWTX)|Pangali Forward P/E QLGN|Rega marang bathi mangsa ngarep ALVR (AlloVir)|Pangali Forward P/E VBIV (VBI Vaccines, Inc.)|Kapitalisasi marang proyeksi bathi virios.com (VIRI)